Atypical Neuroleptics

Citations 21-30 of 335 total displayed.

Past content (since Jun 2002):

Editorials
Bipolar Drug Development: Are We Getting Closer to the Real World?

Joseph R. Calabrese and David E. Kemp
Am J Psychiatry 2008; 165: 1234-1236. [Full text] [PDF]  

Articles
Olanzapine in the Treatment of Low Body Weight and Obsessive Thinking in Women With Anorexia Nervosa: A Randomized, Double-Blind, Placebo-Controlled Trial

Hany Bissada, Giorgio A. Tasca, Ann Marie Barber, and Jacques Bradwejn
Am J Psychiatry 2008; 165: 1281-1288. [Abstract] [Full text] [PDF]  

Editorials
Cholinergic Agonists as Novel Treatments for Schizophrenia: The Promise of Rational Drug Development for Psychiatry

Jeffrey A. Lieberman, Jonathan A. Javitch, and Holly Moore
Am J Psychiatry 2008; 165: 931-936. [Full text] [PDF]  

Editorials
New Insights Into Clinical Response in Schizophrenia: From Dopamine D₂ Receptor Occupancy to Patients’ Quality of Life

Donald C. Goff
Am J Psychiatry 2008; 165: 940-943. [Full text] [PDF]  

Clinical Case Conference
Schizophrenia in a Patient With Spinocerebellar Ataxia 2: Coincidence of Two Disorders or a Neurodegenerative Disease Presenting With Psychosis?

Matthew Rottnek, Silvana Riggio, William Byne, Mary Sano, Russell L. Margolis, and Ruth H. Walker
Am J Psychiatry 2008; 165: 964-967. [Full text] [PDF]  

Articles
Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [¹⁸F]Fallypride PET Study

Gerhard Gründer, Christine Fellows, Hildegard Janouschek, Tanja Veselinovic, Christian Boy, Anno Bröcheler, Katrin M. Kirschbaum, Sandra Hellmann, Katja M. Spreckelmeyer, Christoph Hiemke, Frank Rösch, Wolfgang M. Schaefer, and Ingo Vernaleken
Am J Psychiatry 2008; 165: 988-995. [Abstract] [Full text] [PDF]  

Articles
Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

Anantha Shekhar, William Z. Potter, Jeffrey Lightfoot, John Lienemann, Sanjay Dubé, Craig Mallinckrodt, Frank P. Bymaster, David L. McKinzie, and Christian C. Felder
Am J Psychiatry 2008; 165: 1033-1039. [Abstract] [Full text] [PDF]  

Articles
Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia

Robert Freedman, Ann Olincy, Robert W. Buchanan, Josette G. Harris, James M. Gold, Lynn Johnson, Diana Allensworth, Alejandrina Guzman-Bonilla, Bettye Clement, M. Patricia Ball, Jay Kutnick, Vicki Pender, Laura F. Martin, Karen E. Stevens, Brandie D. Wagner, Gary O. Zerbe, Ferenc Soti, and William R. Kem
Am J Psychiatry 2008; 165: 1040-1047. [Abstract] [Full text] [PDF]  

Editorials
Atypical Antipsychotic Medications in Alzheimer’s Disease: Effectiveness Versus Expectations

Susan K. Schultz
Am J Psychiatry 2008; 165: 787-789. [Full text] [PDF]  

Clinical Case Conference
Rechallenging With Clozapine Following Neutropenia: Treatment Options for Refractory Schizophrenia

Sharmin Ghaznavi, Marina Nakic, Paul Rao, Jian Hu, Judson A. Brewer, Jonas Hannestad, and Zubin Bhagwagar
Am J Psychiatry 2008; 165: 813-818. [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34